Q2 2026 McKesson Corp Earnings Call Transcript
Key Points
- McKesson Corp (MCK) reported a 10% year-over-year increase in consolidated revenues, reaching $103 billion.
- Adjusted earnings per diluted share increased by 39% to $9.86, demonstrating strong financial performance.
- The company raised its guidance on adjusted earnings per diluted share to a range of $38.35 to $38.85.
- Three of McKesson's segments delivered double-digit adjusted operating profit growth, showcasing the strength of its diversified portfolio.
- The newly formed oncology and multi-specialty segment is expected to accelerate growth in higher-margin areas.
- The medical surgical solutions segment experienced softer product demand and lower volumes across ambulatory and extended care settings.
- Revenues from seasonal vaccines and testing volumes represented a 4% headwind compared to the prior year.
- The company anticipates revenue and operating profit at the low end of 2 to 6% growth for the medical surgical solutions segment.
- There are concerns about the impact of potential increases in uninsured patients and cash pay channels on McKesson's prior authorization business.
- The implementation of the Drug Supply Chain Security Act required significant investment, which may not materially drive financial benefits.
Please stand by
Welcome to McKesson's second quarter fiscal 2026 earnings conference call.
Please be advised that today's conference is being recorded at this time, I would like to turn the conference over to Jenny Dominguez, VP of Investor relations.
Please go ahead.
Operator.
Good afternoon and welcome everyone to Mcasson's second quarter, fiscal 2026 earnings call.
Today I'm joined by Brian Tyler, our Chief Executive Officer, and Britt Vitalon, our Chief Financial Officer.
Bryan will lead off, followed by Britt, and then we'll move on to a question-and-answer session.
Today's discussion will include forward-looking statements such as forecasts about McKesson's operations and future results.
Please refer to the cautionary statements in today's earnings release and presentation slides.
Available on our website at investor.mcKesson.com
And to the risk factors section of our most recent annual and periodic
| Access to All Earning Calls and Stock Analysis | |
| 30-Year Financial on one screen | |
| All-in-one Stock Screener with unlimited filters | |
| Customizable Stock Dashboard | |
| Real Time Insider Trading Transactions | |
| 8,000+ Institutional investors’ 13F holdings | |
| Powerful Excel Add-in and Google sheets Add-on | |
| All data downloadable | |
| Quick customer support | |
| And much more... |
Trustpilot
We'd love to learn more about your experiences on GuruFocus.com and how we can improve!
Take Survey
